Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
Next
(2)
•••
jakethesnake2
X
View Profile
View Bullboard History
Post by
jakethesnake2
on Apr 08, 2021 8:09am
News
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease https://seekingalpha.com/pr/18263589-immunoprecise-launches-tatxminus-112-candidate
...more
(22)
•••
wallpaper2
X
View Profile
View Bullboard History
Post by
wallpaper2
on Apr 07, 2021 12:25pm
In case you didn't read or notice them....
IPA's last 2 releases stated: 1- 27 Hamsters with the Covid19 virus were injected ONCE with a single dose of IPA's Antibody Cocktail and all 27 were clear within 3-4 days. 2-
...more
(8)
•••
WsrThanWenYungr
X
View Profile
View Bullboard History
Comment by
WsrThanWenYungr
on Mar 18, 2021 11:43am
RE:IPA and the future
Buy on the dips. Always sound advice. But the dip that's at at the top of a drop... is that really the kind of dip you want to buy at? You say are interested in this stock, as am I, but is this
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Mar 18, 2021 9:18am
Q3 2021 is out and looks great Higher sales and growing
I wish the did better PR but the financials look very strong and the company is definitely a winner with Polytope https://www.businesswire.com/news/home/20210317005871/en/ImmunoPrecise-Reports
...more
(6)
•••
Gummbah
X
View Profile
View Bullboard History
Comment by
Gummbah
on Mar 17, 2021 12:40pm
RE:Fascinated with Fibonacci Retracements.
I am afraid you were a bit wrong 'Cleareye'
(157)
•••
cleareye
X
View Profile
View Bullboard History
Post by
cleareye
on Mar 05, 2021 6:55pm
Fascinated with Fibonacci Retracements.
IPA has a 61.8% Fibonacci Retracement, from the low on November 9th to the high on December 29th, of $14.71. (All figures and chart in Canadian Dollars.) Isn't it interesting that the stock
...more
(157)
•••
cleareye
X
View Profile
View Bullboard History
Post by
cleareye
on Mar 05, 2021 6:07pm
IPA, you dip very well.
70's dance floor talk. Have a good weekend everybody. cleareye.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Mar 02, 2021 11:17am
IPA and the future
Share volume has been low and I think most of the pumpers have left the stock. I took my profits and hold no shares right now. I trade a couple of times but moved on to other stocks. Markets are in a
...more
(13)
•••
bigreturn11
X
View Profile
View Bullboard History
Post by
bigreturn11
on Mar 02, 2021 1:30am
Variants top CNN headline & IPA can manage emerging variants
US coronavirus: All our recent progress with Covid-19 could be wiped out by variants, CDC director says. 'Please stay strong' - CNN IPA CEO comment on LinkedIn tthis evening https://twitter
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Feb 25, 2021 12:29pm
RE:RE:Earnings release in March?
Increased revenue from Talum is about all there is right now. The market is fizzling on Covid vaccines since there are a 4 of them out there. However Polytope if it continues to prove itself will be a
...more
(29)
•••
JonnyLong
X
View Profile
View Bullboard History
Comment by
JonnyLong
on Feb 23, 2021 3:42pm
RE:Earnings release in March?
earnings look to be ~Mar 9 this year ....fingers crossed that your expectations of increased revenue are on the mark.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Feb 22, 2021 10:24am
Earnings release in March?
Last year they released earnings in March. I expect that there will be an increase in revenue and even profit. However I think the cost of listing and trial will generate a neg EPS. This won't
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Feb 19, 2021 10:07am
Want a job
ImmunoPrecise @ImmunoPrecise We are hiring a Research Technician in Oss, The Netherlands! If you would like to work in an exciting
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Feb 19, 2021 9:56am
Polytope success 100%
TATX-03 was 100% efficacious in the preclinical hamster model in treating SARS-CoV-2 infection in a therapeutic setting. IPA’s TATX-03 PolyTope antibody cocktail was administered as a single dose to
...more
Prev
...
21
22
23
24
25
26
27
28
29
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight